Rigel Pharmaceuticals (RIGL) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.75% |
| Dec 31, 2025 | 213.21% |
| Sep 30, 2025 | 73.96% |
| Jun 30, 2025 | 61.00% |
| Mar 31, 2025 | 39.09% |
| Dec 31, 2024 | 39.88% |
| Sep 30, 2024 | 20.89% |
| Jun 30, 2024 | 9.67% |
| Mar 31, 2024 | 2.35% |
| Dec 31, 2023 | -12.70% |
| Sep 30, 2023 | -0.25% |
| Jun 30, 2023 | -8.52% |
| Mar 31, 2023 | -17.08% |
| Dec 31, 2022 | -19.75% |
| Sep 30, 2022 | -38.02% |
| Jun 30, 2022 | -36.51% |
| Mar 31, 2022 | -30.98% |
| Dec 31, 2021 | 51.60% |
| Sep 30, 2021 | 51.57% |
| Jun 30, 2021 | 46.05% |
| Mar 31, 2021 | 50.66% |
| Dec 31, 2020 | -25.20% |
| Sep 30, 2020 | -21.15% |
| Jun 30, 2020 | -11.61% |
| Mar 31, 2020 | -17.03% |
| Dec 31, 2019 | 6.08% |
| Sep 30, 2019 | 26.70% |
| Jun 30, 2019 | 10.58% |
| Mar 31, 2019 | 74.86% |
| Dec 31, 2018 | 16.79% |
| Sep 30, 2018 | 72.87% |
| Jun 30, 2018 | 65.21% |
| Mar 31, 2018 | -2.48% |
| Dec 31, 2017 | 52.44% |
| Sep 30, 2017 | -19.62% |
| Jun 30, 2017 | -13.94% |
| Mar 31, 2017 | -6.42% |
| Dec 31, 2016 | -40.69% |
| Sep 30, 2016 | -36.31% |
| Jun 30, 2016 | -33.05% |
| Mar 31, 2016 | -34.65% |
| Dec 31, 2015 | -14.52% |
| Sep 30, 2015 | -14.73% |
| Jun 30, 2015 | -18.68% |
| Mar 31, 2015 | -18.50% |
| Dec 31, 2014 | -31.82% |
| Sep 30, 2014 | -31.86% |
| Jun 30, 2014 | -30.28% |
| Mar 31, 2014 | -28.15% |
| Dec 31, 2013 | -27.09% |
| Sep 30, 2013 | 23.27% |
| Jun 30, 2013 | 22.07% |
| Mar 31, 2013 | 20.96% |
| Dec 31, 2012 | 20.59% |
| Sep 30, 2012 | -29.56% |
| Jun 30, 2012 | -26.05% |
| Dec 31, 2011 | 37.71% |